Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Movement Disorders : Official Journal of the Movement Disorder Society|March 8, 2016
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsyMaria Stamelou, Jakob Schöpe, Stefan Wagenpfeil, et al.
Journal of Psychopharmacology (Oxford, England)|June 27, 2019
Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly peopleTeodoro Del Ser, María-Ascensión Zea, Meritxell Valentí, et al.
Journal of Alzheimer'S Disease : JAD|December 25, 2014
A phase II trial of tideglusib in Alzheimer's diseaseSimon Lovestone, Mercè Boada, Bruno Dubois, et al.
International Journal of Molecular Sciences|February 13, 2025
Plasma Biomarkers in the Distinction of Alzheimer's Disease and Frontotemporal DementiaEstrella Gómez-Tortosa, Pablo Agüero-Rabes, Alicia Ruiz-González, et al.
Aging Clinical and Experimental Research|January 13, 2022
The health status: the ignored risk factor in dementia incidence. NEDICES cohortFélix Bermejo-Pareja, Agustín Gómez de la Cámara, Teodoro Del Ser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsDarren M Lipnicki, Meritxell Valentí, Elizabeth Valeriano-Lorenzo, et al.
Gerontology|January 11, 2021
Residence, Clinical Features, and Genetic Risk Factors Associated with Symptoms of COVID-19 in a Cohort of Older People in MadridTeodoro Del Ser, Miguel A Fernández-Blázquez, Meritxell Valentí, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Poor dream recall associates with Alzheimer's disease biomarkers and dementia riskDarren M Lipnicki, Meritxell Valentí, Elizabeth Valeriano-Lorenzo, et al.
Aging and Disease|November 21, 2024
Plasma Neurodegenerative Biomarkers in Cognitively Preserved NonagenariansEstrella Gómez-Tortosa, Pablo Agüero-Rabes, Alicia Ruiz-González, et al.
Alzheimer Disease and Associated Disorders|March 5, 2008
A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI studyTeresa Gómez-Isla, Rafael Blesa, Merce Boada, et al.
Pageof 7